Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis

J Deng, K Heybati, HB Ramaraju, F Zhou, D Rayner… - Infection, 2023 - Springer
Purpose To assess and compare the relative efficacy and safety of anti-SARS-CoV-2
antibody regimens for COVID-19. Methods This systematic review and random-effects …

Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis

M Franchini, M Cruciani… - Clinical …, 2024 - clinicalmicrobiologyandinfection …
Background Plasma collected from recovered patients with COVID-19 (COVID-19
convalescent plasma [CCP]) was the first antibody-based therapy employed to fight the …

Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study

M Rojas, Y Rodríguez, JC Hernández… - BMC Infectious …, 2022 - Springer
Background Convalescent plasma (CP) has been widely used to treat COVID-19 and is
under study. However, the variability in the current clinical trials has averted its wide use in …

Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients

M Weisser, N Khanna, A Hedstueck, ST Sutter… - …, 2022 - Wiley Online Library
Background Efficacy of donated COVID‐19 convalescent plasma (dCCP) is uncertain and
may depend on antibody titers, neutralizing capacity, timing of administration, and patient …

Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary

N Kiss-Dala, BG Szabo, B Lakatos, M Reti, J Szlavik… - Geroscience, 2022 - Springer
Convalescent plasma therapy might be a feasible option for treatment of novel infections.
During the early phases of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV …